Physician profile
Brooke Wolf
NPI 1801980701
$2,402.89
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $889 · 2020: $46.05 · 2022: $41.12 · 2023: $1,394 · 2024: $32.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $852 · Food and Beverage: $574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $852.22 |
| Food and Beverage | $574.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuronetics, INC. | $1,302.07 | 2023 | Neurostar Tms Therapy System |
| Sunovion Pharmaceuticals INC. | $276.06 | 2019 | |
| Allergan, INC. | $158.90 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $148.65 | 2019 | |
| Axsome Therapeutics, INC. | $91.77 | 2023 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $59.97 | 2019 | |
| Shire North American Group INC | $56.14 | 2019 | |
| Abbvie INC. | $41.12 | 2022 | |
| Neurocrine Biosciences, INC. | $40.27 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $40.01 | 2019 | |
| Jazz Pharmaceuticals INC. | $36.39 | 2019 | |
| Lilly USA, LLC | $32.70 | 2024 | Mounjaro |
| Lundbeck LLC | $25.87 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.84 | 2020 | |
| Validus Pharmaceuticals LLC | $18.31 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pernix Therapeutics Holdings, INC. | $16.63 | 2019 | |
| Bausch Health US, LLC | $15.01 | 2019 | |
| Merck Sharp & Dohme LLC | $12.17 | 2019 | |
| Adlon Therapeutics L.P. | $12.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Wolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.